FTC-approved monitor will keep an eye on Endo’s pay-for-delay case

The Federal Trade Commission approved the appointment of Quantic Regulatory Services as a monitor in its case alleging that Endo Pharmaceuticals violated antitrust laws by using pay-for-delay settlements to block consumers’ access to lower-cost…

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive